As a result, the mechanisms underlying the impact of glucagon-like peptide-1 medications on the kidneys are unknown. Clinical trials and animal research support GLP-1 medication usage to treat ...

Oxyntomodulin (OXM) is a peptide hormone released by intestinal L cells after food intake. It acts as a dual agonist of glucagon-like peptide 1 (GLP-1) and glucagon receptors, regulating appetite, ...